MFG
ABBV icon

Mission Financial Group’s AbbVie ABBV Stock Holding History

Mission Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$577K Buy
+2,291
New +$493K 0.48% 54
2025
Q1 		$498K Buy
+2,288
New +$445K 0.46% 58
2021
Q4 		$1.22M Buy
+5,340
New +$631K 1.14% 22

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mission Financial Group's ABBV Position: Q2 2026 in Review

Mission Financial Group opened a new position in AbbVie (ABBV) in Q2 2026: 2,291 shares worth $577K. The stake represents 0.48% of the portfolio and ranks #54 among its holdings. This is a return to the name: Mission Financial Group previously reported a position in ABBV as recently as Q1 2025.

Mission Financial Group first reported a position in ABBV in Q4 2021 and has held it in 3 quarters since. The position peaked at $1.22M in Q4 2021. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mission Financial Group held 2,291 shares of AbbVie worth $577K as of Q2 2026.
  • AbbVie was a new Mission Financial Group position in Q2 2026.
  • AbbVie made up 0.48% of Mission Financial Group's portfolio in Q2 2026, its #54 holding.
  • Mission Financial Group first reported a position in AbbVie in Q4 2021 and has held it in 3 quarters since.
  • Mission Financial Group's AbbVie position peaked at $1.22M in Q4 2021.
  • 4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mission Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.